Shah Gaurav (CIK 1725922) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Sell RCKT (2,409 shares), Sell RCKT (2,728 shares), Sell RCKT (5,990 shares), Sell RCKT (12,279 shares), Buy RCKT (286,028 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 2,409 | $7,261 |
| 2026-05-14 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 2,728 | $9,837 |
| 2026-02-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 5,990 | $20,007 |
| 2026-02-18 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 12,279 | $40,643 |
| 2026-02-13 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Buy | 286,028 | $0 |
| 2025-11-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 6,276 | $18,702 |
| 2025-08-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 2,234 | $6,814 |
| 2025-05-22 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 2,253 | $14,532 |
| 2025-05-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 3,621 | $23,645 |
| 2025-04-14 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Buy | 20,000 | $101,600 |
| 2025-02-25 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Sell | 16,303 | $172,486 |
| 2025-02-13 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | Buy | 81,655 | $0 |
Source: SEC Form 4 filings · as of 2026-05-21